Novo A/S »

Miragen Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-06-30 $26M 2.0M 13.01
2024-03-31 $19M 1.1M 17.51

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Tempus Ai Cl A
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
BioMarin Pharmaceutical (BMRN)
Merus N V (MRUS)
Apple (AAPL)

View all positions for Novo A/S

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
VR Adviser
Vanguard Group
Maverick Capital
Paradigm Biocapital Advisors
State Street Corporation
Commodore Capital
Novo A/S
Alliancebernstein
Fairmount Funds Management
Kynam Capital Management
Vivo Capital
Perceptive Advisors

View all funds holding Miragen Therapeutics